Related Experiment Video

Updated: May 17, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Tissue microarray analysis of cyclin-dependent kinase inhibitors p21 and p16 in Fuchs dystrophy

Mario Matthaei1, Eva-Maria Lackner, Huan Meng

  • 1The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21231, USA.

Cornea
|November 8, 2012
PubMed
Abstract

Insights

Tissue microarray technology revealed increased p21 and p16 protein expression in Fuchs endothelial corneal dystrophy (FECD), suggesting cellular senescence contributes to FECD pathogenesis.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cellular Senescence

Background:

  • Fuchs endothelial corneal dystrophy (FECD) is a progressive corneal disease.
  • Cellular senescence, a state of irreversible growth arrest, is implicated in various pathologies.
  • Senescence-associated cyclin-dependent kinase inhibitors, p21 and p16, are key regulators of the cell cycle.

Purpose of the Study:

  • To evaluate the utility of tissue microarray (TMA) technology in corneal disease research.
  • To investigate the expression levels of p21 and p16 in the corneal endothelium of FECD patients.
  • To explore the potential role of cellular senescence in FECD pathogenesis.

Main Methods:

  • A tissue microarray (TMA) was constructed using corneal tissues from FECD patients, keratoconus patients, and nonpathologic controls.
  • TMA sections were immunolabeled for p21 and p16.
  • Protein expression levels were quantified using a standardized scoring system, with validation by whole tissue section analysis.

Main Results:

  • TMA analysis showed significantly increased endothelial expression of p21 in FECD specimens.
  • An altered expression pattern of p16 was observed in FECD endothelium.
  • Validation studies confirmed statistically significant overexpression of both p21 and p16 in the corneal endothelium of FECD patients.

Conclusions:

  • Tissue microarray (TMA) technology is a valuable tool for high-throughput molecular profiling of corneal tissues.
  • Overexpression of p21 and p16 in FECD corneal endothelium supports the involvement of cellular senescence in FECD.
  • These findings provide insights into the molecular mechanisms underlying FECD and suggest potential therapeutic targets.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...